Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 4 (2007), Issue 11 (November)

1. Apoptosis in the kidneys of patients with type II diabetic nephropathy.
   Kidney Int, 72(10): 1262-72. [Abstract] [Full-text]
2. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus.
   Science, 318(5851): 806-9. [Abstract] [Full-text]
3. Ocular comorbidities among cataract-operated patients in rural China: the caring is hip Study of Cataract Outcomes and Uptake of Services (SCOUTS), report No. 3.
   Ophthalmology, 114(11): e47-52. [Abstract] [Full-text]
4. Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema.
   Ophthalmology, 114(11): 2061-9. [Abstract] [Full-text]
5. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.
   Cell, 131(3): 476-91. [Abstract] [Full-text]
6. Accuracy of a single fetal weight estimation at 29-34 weeks in diabetic pregnancies: can it predict large-for-gestational-age infants at term?
   Am J Obstet Gynecol, 197(5): 497.e1-6. [Abstract] [Full-text]
7. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study.
   Am J Obstet Gynecol, 197(5): 492.e1-7. [Abstract] [Full-text]
8. Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials.
   J Am Geriatr Soc, 55(11): 1735-40. [Abstract] [Full-text]
9. Emerging pharmacotherapies for diabetic macular edema.
   Expert Opin Emerg Drugs, 12(4): 591-603. [Abstract] [Full-text]
10. Segmental infarction of the testis: an exceptional complication of diabetes microangiopathy.
    Int J Impot Res, 19(6): 615-6. [Abstract] [Full-text]
11. Effect of postprandial hyperglycaemia on blood viscosity in aged patients suffering from type 2 diabetes as compared with healthy volunteers.
    Blood Coagul Fibrinolysis, 18(8): 745-50. [Abstract] [Full-text]
12. Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones.
    BJU Int, 100(6): 1339-43. [Abstract] [Full-text]
13. Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors.
    BJU Int, 100(6): 1385-90. [Abstract] [Full-text]
14. Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system.
    Eur J Endocrinol, 157(5): 647-53. [Abstract] [Full-text]
15. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.
    Eur J Endocrinol, 157(5): 641-5. [Abstract] [Full-text]
16. Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
    Circulation, 116(19): 2119-26. [Abstract] [Full-text]
17. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
    Pharm Res, 24(12): 2198-206. [Abstract] [Full-text]
18. A 63-year-old man with multiple cardiovascular risk factors and poor adherence to treatment plans.
    JAMA, 298(17): 2048-55. [Abstract] [Full-text]
19. Expectations held by type 1 and 2 diabetes mellitus patients and their relatives: the importance of facilitating the health-care process.
    Health Expect, 10(4): 337-49. [Abstract] [Full-text]
20. Involvement of glomerular SREBP-1c in diabetic nephropathy.
    Biochem Biophys Res Commun, 364(3): 502-8. [Abstract] [Full-text]
21. A comparison of sural nerve conduction studies in patients with impaired oral glucose tolerance test.
    Acta Neurol Scand, 116(6): 399-405. [Abstract] [Full-text]
22. Is the influence of variation in the ACE gene on the prospective risk of Type 2 diabetes in middle-aged men modified by obesity?
    Clin Sci (Lond), 113(12): 467-72. [Abstract] [Full-text]
23. Genetic polymorphisms in susceptibility to Type 1 Diabetes.
    Clin Chim Acta, 387(1): 9-17. [Abstract] [Full-text]
24. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.
    Am J Hum Genet, 81(6): 1284-8. [Abstract] [Full-text]
25. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
    Metabolism, 56(12): 1682-8. [Abstract] [Full-text]
26. Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.
    Metabolism, 56(12): 1652-5. [Abstract] [Full-text]
27. The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes.
    Expert Opin Pharmacother, 8(17): 3009-20. [Abstract] [Full-text]
28. Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus.
    Expert Opin Pharmacother, 8(17): 2895-901. [Abstract] [Full-text]
29. Hyperglycaemic hyperosmolar nonketotic state as a cause of low gonadotrophin levels in postmenopausal diabetic women: a role for severe hypernatraemia.
    J Neuroendocrinol, 19(12): 983-7. [Abstract] [Full-text]
30. Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats.
    J Neuroendocrinol, 19(12): 941-51. [Abstract] [Full-text]
31. Hypertension increases pro-oxidant generation and decreases antioxidant defense in the kidney in early diabetes.
    Am J Nephrol, 28(1): 133-42. [Abstract] [Full-text]
32. Effect of long-term type 1 diabetes on renal sodium and water transporters in rats.
    Am J Nephrol, 28(1): 107-14. [Abstract] [Full-text]
33. Waist circumference is strongly associated with renal resistive index in normoalbuminuric patients with type 2 diabetes.
    Am J Nephrol, 28(1): 54-8. [Abstract] [Full-text]
34. Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats.
    Am J Nephrol, 28(1): 25-33. [Abstract] [Full-text]
35. Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin.
    Am J Nephrol, 28(1): 14-24. [Abstract] [Full-text]
36. Insulin treatment enhances the myocardial angiogenic response in diabetes.
    J Thorac Cardiovasc Surg, 134(6): 1453-60; discussion 1460. [Abstract] [Full-text]
37. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
    Lancet, 370(9600): 1687-97. [Abstract] [Full-text]
38. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.
    Br J Ophthalmol, 91(12): 1599-601. [Abstract] [Full-text]
39. Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography.
    Br J Ophthalmol, 91(12): 1596-8. [Abstract] [Full-text]
40. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
    J Neurol Neurosurg Psychiatry, 78(12): 1325-30. [Abstract] [Full-text]
41. The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.
    Br J Ophthalmol, 91(12): 1593-5. [Abstract] [Full-text]
42. QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA.
    Nutr Metab Cardiovasc Dis, 17(10): 712-8. [Abstract] [Full-text]
43. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
    Nutr Metab Cardiovasc Dis, 17(10): 734-40. [Abstract] [Full-text]
44. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Transl Res, 150(6): 343-9. [Abstract] [Full-text]
45. Use of a registry-generated audit, feedback, and patient reminder intervention in an internal medicine resident clinic--a randomized trial.
    J Gen Intern Med, 22(12): 1740-4. [Abstract] [Full-text]
46. Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus.
    Toxicol Appl Pharmacol, 225(2): 123-33. [Abstract] [Full-text]
47. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial.
    J Gen Intern Med, 22(12): 1695-703. [Abstract] [Full-text]
48. Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis.
    Toxicol Appl Pharmacol, 225(2): 214-20. [Abstract] [Full-text]
49. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management?
    J Gen Intern Med, 22(12): 1635-40. [Abstract] [Full-text]
50. Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose.
    Atherosclerosis, 195(2): 277-86. [Abstract] [Full-text]
51. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF).
    Biomaterials, 29(5): 587-96. [Abstract] [Full-text]
52. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
    Arterioscler Thromb Vasc Biol, 27(12): 2777-82. [Abstract] [Full-text]
53. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.
    Arterioscler Thromb Vasc Biol, 27(12): 2589-96. [Abstract] [Full-text]
54. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes.
    Int J Androl, 30(6): 500-7. [Abstract] [Full-text]
55. Occurrence of oxidative impairments, response of antioxidant defences and associated biochemical perturbations in male reproductive milieu in the Streptozotocin-diabetic rat.
    Int J Androl, 30(6): 508-18. [Abstract] [Full-text]
56. Comparing diabetes prevalence between African Americans and Whites of similar socioeconomic status.
    Am J Public Health, 97(12): 2260-7. [Abstract] [Full-text]
57. The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes.
    Pediatr Res, 62(6): 746-9. [Abstract] [Full-text]
58. High-normal C-reactive protein levels do not affect the vitamin A transport complex in serum of children and adolescents with type 1 diabetes.
    Pediatr Res, 62(6): 741-5. [Abstract] [Full-text]
59. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
    Am Heart J, 154(6): 1078-84, 1084.e1. [Abstract] [Full-text]
60. A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
    Am J Kidney Dis, 50(6): 946-51. [Abstract] [Full-text]
61. Type 1 diabetes as a relapsing-remitting disease?
    Nat Rev Immunol, 7(12): 988-94. [Abstract] [Full-text]
62. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease.
    Int J Cardiol, 123(1): 34-42. [Abstract] [Full-text]
63. Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980-2005.
    Am J Epidemiol, 166(12): 1374-80. [Abstract] [Full-text]
64. Association of diabetes, homocysteine, and HDL with cognition and disability after stroke.
    Neurology, 69(22): 2054-62. [Abstract] [Full-text]
65. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting.
    Interact Cardiovasc Thorac Surg, 6(6): 753-8. [Abstract] [Full-text]
66. Does bilateral internal thoracic artery harvest increase the risk of mediastinitis?
    Interact Cardiovasc Thorac Surg, 6(6): 787-91. [Abstract] [Full-text]
67. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals.
    Diabetes, 56(12): 3082-8. [Abstract] [Full-text]
68. Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women.
    Diabetes, 56(12): 3075-81. [Abstract] [Full-text]
69. A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Diabetes, 56(12): 2990-6. [Abstract] [Full-text]
70. Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes.
    Diabetes, 56(12): 3027-32. [Abstract] [Full-text]
71. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
    Diabetes, 56(12): 2982-9. [Abstract] [Full-text]
72. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets.
    Diabetes, 56(12): 3063-74. [Abstract] [Full-text]
73. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    Diabetes, 56(12): 3014-9. [Abstract] [Full-text]
74. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations.
    Diabetes, 56(12): 3053-62. [Abstract] [Full-text]
75. A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array.
    Diabetes, 56(12): 3045-52. [Abstract] [Full-text]
76. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies.
    Diabetes, 56(12): 3033-44. [Abstract] [Full-text]
77. Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4 alpha (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians.
    Diabetes, 56(12): 3112-7. [Abstract] [Full-text]
78. Aberrant endometrial features of pregnancy in diabetic NOD mice.
    Diabetes, 56(12): 2919-26. [Abstract] [Full-text]
79. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.
    Diabetes, 56(12): 3105-11. [Abstract] [Full-text]
80. LPIN2 is associated with type 2 diabetes, glucose metabolism, and body composition.
    Diabetes, 56(12): 3020-6. [Abstract] [Full-text]
81. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.
    Diabetes, 56(12): 3101-4. [Abstract] [Full-text]
82. Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes.
    Diabetes, 56(12): 2872-7. [Abstract] [Full-text]
83. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.
    Diabetes, 56(12): 3095-100. [Abstract] [Full-text]
84. Childhood predictors of young-onset type 2 diabetes.
    Diabetes, 56(12): 2964-72. [Abstract] [Full-text]
85. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes.
    Diabetes, 56(12): 2997-3005. [Abstract] [Full-text]
86. Variants in the Ca V 2.3 (alpha 1E) subunit of voltage-activated Ca2+ channels are associated with insulin resistance and type 2 diabetes in Pima Indians.
    Diabetes, 56(12): 3089-94. [Abstract] [Full-text]
87. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.
    Nature, 450(7170): 712-6. [Abstract] [Full-text]
88. Assessing subclinical tactual deficits in the hand function of diabetic blind persons at risk for peripheral neuropathy.
    Arch Phys Med Rehabil, 88(12): 1662-72. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.